Snowball logo
logo
ARDS

Aridis Pharmaceuticals Inc

ARDS β€’ NASDAQ
$0.0001$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20182019202020212022TTM
Revenue
Total revenue
2.7571.02211.53519.2520.06
COGS
23-----
Gross Profit
2.7571.02211.535--
Operating Expenses & Income
Operating Income
(24.12)(29.09)(22.4)(43.71)(29.99)(0.883)
Total Operating Expenses
26.8730.1123.443.7129.9920.53
R&D Expenses
2324.0816.9637.9425.9217.38
Selling General & Admin Expenses
3.8746.0266.4457.317.1615.861
Earnings from Continuing Operations
Interest Expense
(0.42)--0.245(0.378)(0.031)
Interest Income
0.380.5940.0770.002--
Income Tax Expense
2.432(0.695)(0.405)(0.912)0.3780.463
Net Income
Net Income
(22.11)(28.99)(22.33)(42.28)(30.75)(1.142)
Supplemental
EBIT
(24.12)(29.09)(22.33)(43.44)(29.99)(0.656)
EBITDA
(23.83)(28.75)31.47(43)(29.51)(0.574)
In millions of USD, except % and values per 1 share